TCR-based Therapies Virtual Summit

Conference themes
The only dedicated end-to-end, industry led TCR therapy summit is a unique opportunity to delve into the details of TCR development. This technical meeting is a rare opportunity to learn from 20+ industry experts from Ziopharm, Immatics US, TScan Therapeutics and many more. Gain insights on their various approaches and be the first to hear cutting-edge data from this fast-paced industry.

A 23.1% growth rate since 2009 spells progress in the TCR-Based therapies space.

Professional congress organizer (PCO)
Hanson Wade

Notes
Speakers: Laurence Cooper, Chief Executive Officer, Ziopharm Oncology, Robert Hofmeister, Chief Scientific Officer, TCR2, Cheng Liu, Chief Executive Officer, Eureka Therapeutics, and more.

Brochure: https://go.evvnt.com/552190-0?pid=4832

Mr. TCR-Based Therapies Virtual Summit